|
APEX1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.477200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.436400E-01 |
| Normal-vs-Stage2 |
7.357400E-01 |
| Normal-vs-Stage3 |
1.729790E-01 |
| Normal-vs-Stage4 |
4.230400E-01 |
| Stage1-vs-Stage2 |
9.279200E-01 |
| Stage1-vs-Stage3 |
2.482600E-01 |
| Stage1-vs-Stage4 |
6.198200E-01 |
| Stage2-vs-Stage3 |
5.240800E-01 |
| Stage2-vs-Stage4 |
8.125000E-01 |
| Stage3-vs-Stage4 |
6.249800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.651600E-02 |
| Normal-vs-AfricanAmerican |
9.131000E-01 |
| Normal-vs-Asian |
6.601800E-01 |
| Caucasian-vs-AfricanAmerican |
4.115400E-01 |
| Caucasian-vs-Asian |
4.674200E-01 |
| AfricanAmerican-vs-Asian |
8.070000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.587020E-01 |
| Normal-vs-Female |
5.600400E-01 |
| Male-vs-Female |
2.285600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.369200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.011000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.574600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.082000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.989200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.328600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.023800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.925800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.815400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.702000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.579200E-01 |
| Classical-VS-Follicular |
1.73440000028613E-07 |
| Classical-VS-Other |
8.294400E-01 |
| Classical-VS-Normal |
1.839980E-02 |
| Tall-VS-Follicular |
1.952220E-04 |
| Tall-VS-Other |
8.957000E-01 |
| Tall-VS-Normal |
3.743900E-02 |
| Follicular-VS-Other |
6.277600E-02 |
| Follicular-VS-Normal |
3.622300E-03 |
| Other-VS-Normal |
5.280800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.146600E-01 |
| Normal-vs-N1 |
9.112600E-01 |
| N0-vs-N1 |
8.855400E-01 |
|
|
